Recurrent syncope and cardiac arrest in a patient with systemic light chain amyloidosis treated with bortezomib

Recurrent syncope and cardiac arrest in a patient with systemic light chain amyloidosis treated with bortezomib

About 10-15% of patients with multiple myeloma develop light chain (AL) amyloidosis. AL amyloidosis is a systemic disease that may involve multiple organs, often including the heart. It may present clinically with bradyarrhythmia and syncope. The proteasome inhibitor bortezomib has been used with cl...

Full description

Bibliographic Details
Main Authors: Navin Jaipaul, Alexander Pi, Zhiwei Zhang
Format: Article
Language:English
Published: PAGEPress Publications 2016-05-01
Series:Hematology Reports
Subjects:
Light chain amyloidosis
bortezomib
syncope
cardiac arrest
Online Access:http://www.pagepress.org/journals/index.php/hr/article/view/6417

Similar Items

Similar Items